Product

Dapagliflozin propanediol

1 clinical trial

4 indications

Indication
STEMI
Indication
NSTEMI
Clinical trial
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
Status: Recruiting, Estimated PCD: 2026-01-09